Treating hepatitis C saves lives and is cost-effective
Treating people who inject drugs for hepatitis C with new therapies is cost-effective and could prevent liver-related deaths.
Download report
Associate Professor Nick Scott
Dr Nick Scott, BSc (hons), PhD (Mathematics) is the Head of Modelling & Biostatistics at the Burnet Institute, an Adjunct Senior Research Fellow at Monash University, and an NHMRC Emerging Leader Fellow. He leads a team of modellers who work across a number of infectious diseases and public health problems.
EMAIL